E-cadherin expression is often used as a marker to monitor EMT and MET events; however, the extent to which E-cadherin itself is required to restrain invasion at the primary tumor site or to promote growth upon MET at a secondary tumor site remains the subject of ongoing investigation. The gene discussed is CDH1; the disease is neoplasm.